This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy and safety of GHB in prevention and treatment of the AWS, more specifically • to compare the efficacy of GHB with placebo or other drugs; • to identify the most effective GHB dosage and schedules; • to estimate the incidence of side effects; • to carry out a risk-benefit analysis.
Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal
VIGNA-TAGLIANTI, Federica;
2006-01-01
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy and safety of GHB in prevention and treatment of the AWS, more specifically • to compare the efficacy of GHB with placebo or other drugs; • to identify the most effective GHB dosage and schedules; • to estimate the incidence of side effects; • to carry out a risk-benefit analysis.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
